Amarin Corp. ADR (AMRN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

GEMINI HOUSE ELY CAMBRIDGESHIRE, UNITED KINGDOM FK7 9JQ

Amarin Corp. focuses on the research, development and commercialization of novel drugs for treatment of central nervous system disorders. This neuroscience company has headquarters in London and a R&D facility in Scotland. Its lead product, Miraxion, is in phase III development for Huntington's disease.

Data based on most recent fiscal year report
Market Cap7.526 Billion Shares Outstanding357.21 Million Avg Volume11.093 Million
1-Yr BETA vs S&P TR1.289 Current Ratio2.4 Quick Ratio2.04
View SEC Filings from AMRN instead.

View recent insider trading info

Funds Holding AMRN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AMRN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

200 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

1 Million total shares from 34 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ZAKRZEWSKI JOSEPH S

  • Director
30,000 2020-03-17 5

THERO JOHN F PRESIDENT AND CEO

2,480,441 2020-03-04 12

KENNEDY JOSEPH T GENERAL COUNSEL

193,507 2020-02-28 9

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

516,012 2020-02-28 6

PETERSON KRISTINE

0 2020-02-28 1

KALB MICHAEL WAYNE SVP AND CFO

83,927 2020-02-28 5

BERG AARON CHIEF COMMERCIAL OFFICER

188,905 2020-02-28 8

STACK DAVID M CEO AND CHAIRMAN

  • Officer
  • Director
218,138 2020-02-21 3

HEALY JAMES

  • Director
  • 10% Owner
0 2020-01-21 0

AHLHOLM FREDERICK W SVP, CHIEF ACCOUNTING OFFICER

  • Officer
0 2019-12-31 0

EKMAN LARS

  • Director
0 2019-12-17 4

ABINGWORTH LLP

  • FORMER 10% OWNER
2,144,517 2019-11-12 0

GORDON CARL L

  • Director
  • 10% Owner
0 2019-09-12 0

VAN HEEK G JAN

  • Director
13,333 2019-06-26 1

O'SULLIVAN PATRICK J

  • Director
0 2019-05-20 1

SONI PARESH CHIEF MEDICAL OFFICER

  • Officer
0 2018-06-08 0

SALYER MARK CHIEF COMMERCIAL OFFICER

  • Officer
0 2018-02-01 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP III LLC

ISALY SAMUEL D

  • 10% Owner
5,550,000 2018-01-03 0

FARRELL MICHAEL JAMES VP, FINANCE

  • Officer
30,190 2016-01-31 0

SOFINNOVA VENTURE PARTNERS VII L P

SOFINNOVA MANAGEMENT VII, L.L.C.

HEALY JAMES

BUATOIS ERIC

POWELL MICHAEL

  • 10% Owner
No longer subject to file 2014-07-09 0

SEDLACK STUART D SENIOR VICE PRESIDENT

  • Officer
0 2012-07-26 0

HUFF PAUL CHIEF COMMERCIAL OFFICER

  • Officer
0 2012-07-26 0

ANDERSON JOSEPH

  • Director
0 2012-07-10 0

FOUNTAIN HEALTHCARE PARTNERS LTD.

  • Director
2,517,391 2011-09-30 0

FEIGAL DAVID W JR

  • Director
0 2011-07-12 0

ROGAN MANUS

  • Director
17,391 2011-01-01 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

THERO JOHN F PRESIDENT AND CEO

2020-03-04 S 200,000 $15.99 d 2,480,441 2,480,441.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-03-02 A 49,000 a 49,000 516,012.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-03-02 A 178,100 a 178,100 2,680,441.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-03-02 A 49,000 a 49,000 188,905.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-03-02 A 49,000 a 49,000 83,927.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-03-02 A 49,000 a 49,000 193,507.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-02-28 M 1,528 a 188,883 188,905.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-02-28 M 1,528 d 27,498 83,927.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-02-28 M 1,528 a 83,897 83,927.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-02-28 M 1,806 d 32,497 193,507.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-02-28 F 1,506 $14.67 d 516,012 516,012.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-02-28 F 5,302 $14.67 d 2,680,441 2,680,441.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-02-28 F 1,506 $14.67 d 188,905 188,905.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-02-28 F 1,498 $14.67 d 83,927 83,927.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-02-28 M 1,806 a 193,507 193,507.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-02-28 M 1,528 d 27,498 516,012.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-02-28 M 1,528 a 517,518 516,012.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-02-28 M 6,736 d 121,249 2,680,441.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-02-28 M 6,736 a 2,685,743 2,680,441.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-02-28 M 1,528 d 27,498 188,905.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-02-28 M 1,528 a 190,411 188,905.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-02-28 M 1,528 d 27,498 83,927.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-02-28 M 1,528 a 85,425 83,927.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-02-28 M 1,806 d 32,497 193,507.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-02-28 M 1,806 a 191,701 193,507.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-02-28 M 1,528 d 27,498 516,012.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-02-28 M 1,528 a 515,990 516,012.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-02-28 M 6,736 d 121,249 2,680,441.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-02-28 M 6,736 a 2,679,007 2,680,441.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-02-28 M 1,528 d 27,498 188,905.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-02-25 A 55,000 a 55,000 82,369.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-02-25 F 25,440 $17.58 d 82,369 82,369.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-02-25 M 30,697 d 34,303 189,895.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-02-25 A 65,000 a 65,000 189,895.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-02-25 M 30,697 a 191,522 189,895.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-02-25 M 25,974 d 29,026 514,462.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-02-25 M 25,974 a 540,048 514,462.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-02-25 A 242,500 a 242,500 2,672,271.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-02-25 M 25,974 d 29,026 187,355.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-02-25 F 90,124 $17.58 d 2,672,271 2,672,271.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-02-25 A 55,000 a 55,000 187,355.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-02-25 M 25,974 a 186,967 187,355.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-02-25 M 25,974 d 29,026 82,369.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-02-25 M 25,974 a 107,809 82,369.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-02-25 A 65,000 a 65,000 189,895.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-02-25 F 32,324 $17.58 d 189,895 189,895.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-02-25 M 25,974 d 29,026 514,462.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-02-25 A 55,000 a 55,000 514,462.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-02-25 M 25,974 a 514,074 514,462.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-02-25 M 114,515 d 127,985 2,672,271.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-02-25 A 55,000 a 55,000 187,355.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-02-25 M 114,515 a 2,762,395 2,672,271.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-02-25 F 25,586 $17.58 d 187,355 187,355.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-02-25 M 25,974 d 29,026 82,369.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-02-25 A 55,000 a 55,000 82,369.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-02-25 M 25,974 a 81,835 82,369.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-02-25 M 30,697 d 34,303 189,895.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-02-25 M 30,697 a 222,219 189,895.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-02-25 A 55,000 a 55,000 514,462.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-02-25 F 25,586 $17.58 d 514,462 514,462.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-02-25 M 114,515 d 127,985 2,672,271.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-02-25 A 242,500 a 242,500 2,672,271.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-02-25 M 25,974 d 29,026 187,355.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-02-25 M 114,515 a 2,647,880 2,672,271.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-02-25 M 25,974 a 212,941 187,355.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-02-03 A 96,500 a 96,500 160,825.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-02-03 A 96,500 a 96,500 160,993.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-02-03 A 96,500 a 96,500 55,861.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-02-03 A 350,700 a 350,700 2,533,365.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-02-03 A 96,500 a 96,500 488,100.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-01-31 M 29,000 a 162,806 160,993.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-01-31 M 119,666 a 2,461,951 2,533,365.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-01-31 M 26,000 d 26,000 55,861.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-01-31 M 12,734 a 89,286 55,861.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-01-31 M 36,000 d 0 160,825.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-01-31 M 26,000 a 187,723 160,825.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-01-31 M 12,734 d 25,466 488,100.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-01-31 F 33,603 $19.04 d 488,100 488,100.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-01-31 M 29,000 a 482,969 488,100.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-01-31 M 123,667 d 123,666 2,533,365.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-01-31 F 14,547 $19.04 d 160,993 160,993.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-01-31 M 72,034 a 2,657,652 2,533,365.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-01-31 M 29,000 d 0 55,861.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-01-31 M 26,000 a 76,552 55,861.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-01-31 M 12,734 d 25,466 160,825.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-01-31 F 39,632 $19.04 d 160,825 160,825.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-01-31 M 36,000 a 161,723 160,825.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-01-31 M 26,000 d 26,000 488,100.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-01-31 M 12,734 a 521,703 488,100.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-01-31 M 12,734 d 25,466 160,993.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-01-31 M 119,666 d 0 2,533,365.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-01-31 M 12,734 a 175,540 160,993.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-01-31 M 123,667 a 2,585,618 2,533,365.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-01-31 M 12,734 d 25,466 55,861.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-01-31 F 33,425 $19.04 d 55,861 55,861.00 direct

KALB MICHAEL WAYNE SVP AND CFO

2020-01-31 M 29,000 a 50,552 55,861.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-01-31 M 26,000 d 26,000 160,825.00 direct

KENNEDY JOSEPH T GENERAL COUNSEL

2020-01-31 M 12,734 a 200,457 160,825.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-01-31 M 29,000 d 0 488,100.00 direct

KETCHUM STEVEN B CHIEF SCIENTIFIC OFFICER

2020-01-31 M 26,000 a 508,969 488,100.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-01-31 M 72,034 d 144,066 2,533,365.00 direct

BERG AARON CHIEF COMMERCIAL OFFICER

2020-01-31 M 29,000 d 0 160,993.00 direct

THERO JOHN F PRESIDENT AND CEO

2020-01-31 F 124,287 $19.04 d 2,533,365 2,533,365.00 direct

Elevate your investments